• Skip to primary navigation
  • Skip to main content
  • Skip to footer
AKRN

AKRN

Scientific Consulting

  • Services
    • Clinical Services
    • Regulatory Services
    • Quality Management Services
    • Medical Writing
    • Clinical Data Management
    • Statistical Analysis and Reporting
    • Medical Aesthetic Devices
    • COVID-19
  • Team
    • Who we are
    • Our team
    • Code of Ethics
    • Our history
    • Our Community
  • News
    • News
    • Resources
    • Social Network
  • Career Portal
  • Contact
  • English
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

What is MedTech?

June 1, 2020 by AKRN

MedTech, or medical technology, is every product, service, or solution using medical technology to improve people’s health by preventing, diagnosing, monitoring, and treating disease.

Because of this, MedTech products are necessary to improve the patient’s quality of life.

Nowadays, medical technology is so common and so integrated into our everyday life that it is difficult to imagine living without this technology. As an example, early diagnostic tools can be used to prevent disease, and the diagnosis helps doctors to identify specific conditions and provide treatment early. It is said that information is the most powerful tool against disease.

The world is experiencing the dramatic consequences of COVID-19 pandemic. MedTech is saving thousands of lives with medical devices (respirators), in-vitro diagnostic devices (e.g., PCR rapid testing kits), and digital health devices that use the information and communication technologies to inform the population about how to protect themselves from the coronavirus and how to avoid its propagation.

In 2018 the MedTech Industry registered closer to 14,000 patents in the EPO (European Patent Office) in 20181. That is approximately the same number of patents registered in Pharma (7.441) and Biotechnology (6.742), together! The MedTech market is estimated at €115 billion in Europe, and there are 27.000 medical technology companies in Europe with more than 675.000 employees2. The forecast is that in-vitro diagnostic devices will remain the highest selling category of devices, and be the number one device area in 20243.

There is no doubt that the European MedTech market is an attractive and profitable market to enter. But the European Union is also very demanding in terms of regulatory requirements to enter this market, and it is essential to know about all the steps required to obtain market authorization (CE-marking).

Different regulations are required to obtain the CE-mark of the MedTech product: IVDR 2017/746 for in-vitro diagnostic and MDR 2017/746 for medical devices. To enter the European market, you need to have a plan and transition strategy in place for your products to bridge the gap from the previous MDD legislation (or IVDR) to the new MDR (or IVDR) regulation.

Furthermore, additional standards are required to be followed, such as the ISO 14155 standard that describes how to design, conduct, record, and report a clinical investigation with medical devices in human subjects, and the ISO 13485 standard that defines how to set up and maintain a Quality Management System. Also, the ISO 14971:2019 risk analysis standard and the ISO 26304 standard for software, are two other standards required for most product approvals.

References

1- European Patent Office. Annual Report 2018

2- MedTech Europe calculation. Medtecheurope.org

3- Worldwide Medtech Sales by EvaluateMedTech® Device Area: Top 15 Categories & Total Market (2017 – 2024) – http://info.evaluategroup.com/WPMT2018-CS.html

Subject Matter Expert

Maria Nyåkern, Ph.D. Founder & Executive Director LinkedIn

Share this article

Category iconDefinition,  European Union,  Medical Devices,  Medical Technology,  MedTech

Request a free consultation

Our team will help you to find the best solution for your needs. Our medical device experience and clinical knowledge can help you plan, set up, and execute a clinical trial, or performance study, in an optimal way.

Footer

AKRN Spain

AKRN Scientific Consulting S.L.
Address: Calle de Fuerteventura 4 (office 1.8)
Office Park La Marina
Postal Code: ES-28703 Madrid
Phone: +34 910 25 81 40
VAT ID: ES-B87990925

Contact details

Contact email: contact@akrnconsulting.com
Office phone: +34 910 258 140
Office phone: +34 919 333 814
Go to contact

Content

  • Medical Device Consulting Services
  • Clinical Studies for Medical Devices
  • Medical Writing
  • Regulatory Services
  • Contact

Resources

  • Articles
  • Resources
  • Career Portal

Latest articles

  • Artificial Intelligence challenges in Medical Devices
  • What is good clinical practice (GCP)?
  • Drug or Device? Summary and analysis of MDCG 2022-05 on borderline products
  • TRANSITIONAL PROVISIONS according to (EU) 2017/746 ARTICLE 110 IVDR, AN UPDATE WITH MDCGs published in 2022.
  • FELLOW PROGRAM – THE TALENT INCUBATOR OF A CRO
  • AUDITING A QMS ACCORDING TO ISO 13485

AKRN, Now part of NAMSA, is now ISO 9001:2015 quality certified by EQA, a recognized Spanish accredited certification body. The ISO 9001 standard, established by the International Organization for Standardization (ISO), is the quality standard par excellence, and its structure forms the basis for other quality standards such as the medical device quality standard ISO 13485. Implementing ISO 9001:2015 aims to support organizations in enhancing their overall performance and client satisfaction.

AKRN Scientific Consulting S.L ha sido beneficiaria del Fondo Europeo de Desarrollo Regional cuyo objetivo es mejorar la competitividad de las Pymes y gracias al cual ha puesto en marcha un Plan de Marketing Digital Internacional con el objetivo de mejorar su posicionamiento online en mercados exteriores durante el año 2020. Para ello ha contado con el apoyo del Programa XPANDE DIGITAL de la Cámara de Comercio de Burgos.
“Una manera de hacer Europa”

AKRN Scientific Consulting S.L ha sido beneficiaria de la subvención de contratos de trabajo de la Comunidad de Madrid, cofinanciado por el Fondo Social Europeo y la Iniciativa de Empleo Juvenil, en el marco del Programa Operativo de Empleo Juvenil 2014-2020, gestionado por la Consejería de Economía, Empleo y Hacienda.

La empresa (AKRN Scientific Consulting S.L.) es beneficiaria del Programa “la Caixa” Empleo Joven de ayudas para el fomento de la contratación de personas jóvenes. Estas ayudas están cofinanciadas por el Programa Operativo de Empleo Juvenil / Iniciativa de Empleo Juvenil – Fondo Social Europeo y por la Fundación Bancaria “la Caixa”.

 

 

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Privacy policy – Cookie Policy – Legal Notice –  Copyright © 2023. All rights reserved. Return to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview
AKRN

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy